MedKart Pitch Deck Teardown: Targeting India's Tier 2 and 3

Executive Summary: The Digital Transformation of Indian Medical Procurement

MedKart presents a classic B2B marketplace play aimed at one of the most inefficient sectors in the Indian economy: medical supply chains in non-metropolitan areas. The deck outlines a transition from manual, fragmented procurement to a centralized digital platform. With a modest $600k ask, the company is positioning itself for a high-growth trajectory in a market poised to quintuple in size by 2030.

Slide 1: Title and Value Proposition

The opening slide clearly defines the company's niche: 'Streamlining Medical Supplies procurement in the Tier 3 and Tier 2 cities of India.' It highlights three core pillars: Digitalizing Medical Supply, Simplifying Procurement, and Single Window Solutions. The imagery uses a hexagonal grid featuring medical professionals and logistics, immediately signaling a B2B healthcare-meets-logistics focus.

Slide 2: Vision Statement

The vision is 'To be one of the most reliable and largest medical supplies platform in the world focusing on the quality and affordability to its core.' While the vision is global, the rest of the deck remains strictly focused on the Indian domestic market, which is a more realistic starting point for a pre-seed venture.

Slide 3: New Dimension to Business

This slide uses a pyramid graphic to explain the operational benefits. At the base is 'Access to wide range of products,' leading up to 'Data-driven decision making' and 'Inventory optimization.' Key metrics mentioned here include a 'Minimum 12% to 14% of cost saving' for customers and 'Higher cash flows' resulting from minimized inventory days. This slide effectively communicates the 'why' for the customer.

Slide 4: Market Size and Opportunity

MedKart provides a detailed breakdown of the market. They cite the Indian medical device market at $11 Billion in 2020, growing to $50 Billion by 2030 at a CAGR of 16.4%. Crucially, they identify their Serviceable Addressable Market (SAM) as $3.3B. The slide also mentions a goal to touch a GMV of 5,000 crore INR by 2030 with a Net Revenue of 15%. The inclusion of both global and local data helps frame the scale of the opportunity.

Slide 5: Go-To-Market Strategy

The GTM strategy is segmented by geography and customer type. They are targeting 25-400 bed multi-speciality hospitals that currently rely on manual inventory management. The geographic rollout is split into Phase 1 (Delhi NCR, Haryana, Punjab, UP, Uttarakhand) and Phase 2 (East, North-East, and South India). This phased approach suggests a logical, regional expansion plan rather than trying to boil the ocean at once.

Slide 6: Associated Brands & Customers

This is a credibility slide. It lists over 100 brands, including major logos like 3M, Abbott, Johnson & Johnson, and Roche. On the customer side, it lists hospital groups like Cloudnine, Saroj, and Ujala Cygnus. The slide notes that MedKart is onboarding 21 hospitals in Tier II & III in North India. This provides the first hint of actual traction, though it doesn't specify if these are active paying customers or just 'onboarded' to the platform.

Slide 7: Business Model

Product Supply: Margin/Transaction-based revenue. · Finance Wing: Financing/leasing medical equipment. · Tech Tool: Subscription-based revenue for optimization and MIS tools. · Ad Window: Advertisement revenue from principal companies.

This diversified model shows the founders are thinking about multiple ways to monetize the data and relationships they build, moving beyond simple brokerage.

Slide 8: Financials (Post Fund Raise)

The financial table provides a five-year projection. Year 1 shows revenue of INR 44.9 million with a 30.1% EBITDA loss. By Year 3, they project revenue of INR 1,387.4 million and a flip to a 1.1% EBITDA profit. By Year 5, revenue is projected at INR 6,590.8 million with an 11.2% EBITDA margin. The slide also includes a 'Fund Allocation %' pie chart: 30% Operation, 28% Business Development, 22% Manpower, and 20% Technology.

Slide 9: Product Development and Use of Funds

This slide elaborates on the $600k ask. The funds are earmarked for:

Building a B2B online marketplace with a digital catalogue of over 300k products. · Point of Sale/Distribution in the Top 20 Cities of India. · Investing in the full technology stack and supply chain infrastructure. · Building a core team of executive people.

The mention of a 300k product catalogue is an ambitious target for a pre-seed stage company.

Slide 10: Why To Invest

The final slide summarizes the pitch. It states MedKart started its journey on Dec 23, 2024 (which appears to be a future date relative to typical deck creation, or a typo for 2023). It reiterates the $24 million turnover goal and the $600k (Rs. 5 Cr) pre-seed ask for the next 12 months of operation. It frames the investment as a way to 'propel us to the next level.'

What Works in This Deck

The deck is very clear about the problem it is solving and the specific geographic market it is targeting. The focus on Tier 2 and Tier 3 cities is a smart differentiation from larger competitors who often focus on Tier 1 metros. The business model slide is comprehensive, showing a path to high-margin software and finance revenue alongside lower-margin product sales. The inclusion of recognizable brand logos (3M, Abbott) adds immediate institutional credibility to a pre-seed startup.

What Is Missing

The most glaring omission is a Team Slide . In a pre-seed round, investors are primarily betting on the founders' ability to execute. Without knowing who is behind the company, their backgrounds in healthcare or logistics, or their previous successes, it is difficult to validate the aggressive growth projections. Additionally, there is a lack of Unit Economics . While they mention a 15% net revenue target, they don't break down the cost of customer acquisition (CAC) versus the lifetime value (LTV), which is critical for a marketplace model. Finally, the Competition Slide is missing; the deck assumes a vacuum, ignoring existing players like PharmEasy, Retailio, or Moglix that might be encroaching on this space.

Founder's Guide: What to Copy and What to Avoid

Copy the Market Sizing: Slide 4 is a great example of how to break down TAM, SAM, and SOM. It uses credible growth rates and links the macro-opportunity (the sunrise sector) to the company's specific revenue goals. Copy the Credibility Slide: If you have relationships with major brands, show them. Slide 6 does this well by separating suppliers from customers, showing a healthy ecosystem.

Avoid the 'Future Date' Typo: Slide 10 mentions a start date of Dec 23, 2024. If this is a typo, it suggests a lack of attention to detail. If it is a projected start date, it makes the 'traction' mentioned in Slide 6 confusing. Avoid Omission of the Team: Never send a deck without a team slide. At the pre-seed stage, the team is 80% of the investment decision. Avoid Overly Aggressive Financials: Projecting a jump from 44 million to 6.5 billion in revenue over five years requires a massive amount of capital and flawless execution; without a detailed 'how' (like a hiring plan or specific marketing spend), these numbers can look like 'spreadsheet math' to experienced investors.